Disorders of lipid metabolism are responsible for several important established risk factors for cardiovascular disease, which continues to be the leading cause of morbidity and mortality in the United States. Despite of decades of research, many aspects of lipid metabolism are incompletely understood. Proprotein convertases (PCs) were suspected to be involved in lipid metabolism, but their importance has not been fully appreciated until the recent discoveries that two PCs were found to be associated with lipid disorders in humans. The mechanisms by which PCs influence cholesterol metabolism remain unclear. Our long-term goal is to delineate how PCs cleave substrates and regulate lipid metabolism. In this project, we will focus on how PCs influence lipid metabolism through angiopoietin-like 3 (ANGPTL3). This will be accomplished by conducting experiments addressing three Specific Aims.
Specific Aim 1, in cell culture to examine how PCs influence the cellular processing of ANGPTL3 by using different compounds.
Specific Aim 2, in a cell-free system to find out whether the interference of ANGPTL3 processing by PCs has any effects on activity of an enzyme named lipoprotein lipase, then to further examine in mice whether it also affects plasma lipid levels and formation of atherosclerosis in an atherogenic mouse model.
Specific Aim 3 : The physiological relevance of this biological event will be examined under different nutritional states and acute inflammation in mice. This study will be not only important to better understand the biologic processing of ANGPTL3, but also to delineate how PCs regulate lipid metabolism, ultimately, provides information that could lead to the development of potential novel approaches for regulating lipoprotein metabolism and preventing cardiovascular diseases.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
3R01HL081861-04S1
Application #
7840744
Study Section
Integrative Nutrition and Metabolic Processes Study Section (INMP)
Program Officer
Liu, Lijuan
Project Start
2009-07-15
Project End
2012-06-30
Budget Start
2009-07-15
Budget End
2012-06-30
Support Year
4
Fiscal Year
2009
Total Cost
$273,056
Indirect Cost
Name
Suny Downstate Medical Center
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
040796328
City
Brooklyn
State
NY
Country
United States
Zip Code
11203
Basu, Debapriya; Huq, Afroza; Iqbal, Jahangir et al. (2015) Hepatic S1P deficiency lowers plasma cholesterol levels in apoB-containing lipoproteins when LDLR function is compromised. Nutr Metab (Lond) 12:35
Lei, Xia; Basu, Debapriya; Li, Zhiqiang et al. (2014) Hepatic overexpression of the prodomain of furin lessens progression of atherosclerosis and reduces vascular remodeling in response to injury. Atherosclerosis 236:121-30
Basu, Debapriya; Lei, Xia; Josekutty, Joby et al. (2013) Measurement of the phospholipase activity of endothelial lipase in mouse plasma. J Lipid Res 54:282-9
Basu, Debapriya; Manjur, Jahan; Jin, Weijun (2011) Determination of lipoprotein lipase activity using a novel fluorescent lipase assay. J Lipid Res 52:826-32
Lei, Xia; Shi, Fujun; Basu, Debapriya et al. (2011) Proteolytic processing of angiopoietin-like protein 4 by proprotein convertases modulates its inhibitory effects on lipoprotein lipase activity. J Biol Chem 286:15747-56
Liu, Jun; Afroza, Huq; Rader, Daniel J et al. (2010) Angiopoietin-like protein 3 inhibits lipoprotein lipase activity through enhancing its cleavage by proprotein convertases. J Biol Chem 285:27561-70
Jin, Weijun; Wang, Xun; Millar, John S et al. (2007) Hepatic proprotein convertases modulate HDL metabolism. Cell Metab 6:129-36